Skip to content
Trial Eligibility
Menu

Home Based Functional Balance Intervention for Multiple Sclerosis

NCT07355387

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on physical and cognitive function, as well as measures of daily living among persons with multiple sclerosis (PwMS). Combined Specific Aims: Aim 1: Examine the effect of the FBI (Intervention Group) on physical function in PwMS compared to a stretching program (Control Group).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Multiple Sclerosis
  • Multiple Sclerosis (MS) - Relapsing-remitting
  • Multiple Sclerosis (MS) Primary Progressive
  • Multiple Sclerosis (MS) Secondary Progressive
  • Multiple Sclerosis Acute and Progressive

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
40 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Illinois at Chicago
Last updated on ClinicalTrials.gov
January 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • University of Illinois at Chicago · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.